EGFR and urinary bladder carcinoma: The MLPA assay did contain sequences to analyze a limited number of genes, but of several exons; some genes that may have an important role in bladder cancer progression were not included in this assay, e.g. the androgen receptor, which may contribute to disease progression by EGFR signaling48.